Published in Heart Fail Rev on March 01, 2017
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med (2006) 10.58
Spironolactone for heart failure with preserved ejection fraction. N Engl J Med (2014) 7.48
Age-predicted maximal heart rate revisited. J Am Coll Cardiol (2001) 5.84
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev (2007) 4.69
Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation (2005) 4.61
Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol (1997) 4.40
Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol (2010) 3.63
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J (2010) 3.62
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation (2009) 3.55
Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol (2011) 3.19
Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol (2011) 3.13
Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation (2006) 3.01
Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail (2010) 3.01
Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol (2003) 2.76
The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol (2009) 2.61
Echocardiographic evaluation of diastolic function can be used to guide clinical care. Circulation (2009) 2.42
Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation (2014) 2.25
From mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochim Biophys Acta (2009) 2.10
Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J Cardiopulm Rehabil (2006) 2.10
Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol (2012) 2.03
Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin. Circulation (2015) 1.96
Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ Heart Fail (2010) 1.93
Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction. Circ Heart Fail (2014) 1.84
Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ Heart Fail (2009) 1.84
Effect of aging on left ventricular diastolic filling in normal subjects. Am J Cardiol (1987) 1.79
Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22--65 years. Acta Physiol Scand (1978) 1.76
The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (1997) 1.75
Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail (2011) 1.69
Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology (2008) 1.67
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair (2012) 1.65
Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol (2012) 1.59
Aging and Cardiac Fibrosis. Aging Dis (2011) 1.58
Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation (2001) 1.58
Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res (2014) 1.56
The pathophysiology of heart failure with preserved ejection fraction. Nat Rev Cardiol (2014) 1.48
Age related changes of the collagen network of the human heart. Mech Ageing Dev (2001) 1.47
Age-related changes in the proportion of types I and III collagen. Mech Ageing Dev (1988) 1.44
Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol (2014) 1.43
Determinants of Effort Intolerance in Patients With Heart Failure: Combined Echocardiography and Cardiopulmonary Stress Protocol. JACC Heart Fail (2015) 1.43
Age and flow-mediated dilation: a comparison of dilatory responsiveness in the brachial and popliteal arteries. Am J Physiol Heart Circ Physiol (2006) 1.36
Collagen accumulation in heart ventricles as a function of growth and aging. Cardiovasc Res (1989) 1.33
Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail (2013) 1.30
Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function. Circ Heart Fail (2015) 1.29
Left ventricular ejection fraction and volumes: it depends on the imaging method. Echocardiography (2013) 1.28
Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass. J Gerontol A Biol Sci Med Sci (2013) 1.27
Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J (2012) 1.24
Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction. Am J Physiol Heart Circ Physiol (2006) 1.24
Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin (2012) 1.22
Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation. Circ Res (2013) 1.20
Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol (2014) 1.19
Relationship of flow-mediated arterial dilation and exercise capacity in older patients with heart failure and preserved ejection fraction. J Gerontol A Biol Sci Med Sci (2012) 1.14
Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. Cardiovasc Res (2012) 1.11
CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF. JACC Cardiovasc Imaging (2014) 1.04
Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle. Eur J Heart Fail (2015) 1.03
Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium. Circ Res (2014) 1.03
G-proteins in growth and apoptosis: lessons from the heart. Oncogene (2001) 1.03
Action potential prolongation in cardiac myocytes of old rats is an adaptation to sustain youthful intracellular Ca2+ regulation. J Mol Cell Cardiol (2002) 0.96
Dynamics of left ventricular filling at rest and during exercise. Circulation (1983) 0.96
Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem. J Geriatr Cardiol (2015) 0.95
Reduced collagenolytic activity of matrix metalloproteinases and development of liver fibrosis in the aging rat. Mech Ageing Dev (2002) 0.94
Dynamic changes in myocardial matrix and relevance to disease: translational perspectives. Circ Res (2014) 0.92
Principles of exercise physiology: responses to acute exercise and long-term adaptations to training. PM R (2012) 0.88
Invasive hemodynamic characterization of heart failure with preserved ejection fraction. Heart Fail Clin (2014) 0.87
Exercise physiology in heart failure and preserved ejection fraction. Heart Fail Clin (2014) 0.86
Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy. Circ Heart Fail (2011) 0.86
Mechanisms of exercise intolerance in heart failure with preserved ejection fraction. Circ J (2013) 0.84
Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. J Card Fail (2014) 0.84
Left ventricular stiffening as therapeutic target for heart failure with preserved ejection fraction. Circ J (2013) 0.80
Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction. Int J Cardiol (2015) 0.78